is conditionally recommended over the use of IA glucocorticoids alone for patients taking DMARDs who are not at target This recommendation was based on the premise that DMARDs should be adjusted to reduce disease activity, irrespective of treatment with IA glucocorticoids. The recommendation is conditional because patients may choose to defer adding/switching DMARDs if they obtain relief from IA injection(s). Recommendations for tapering/discontinuing DMARDs (Table 5) Because of the